Information  X 
Enter a valid email address

Company Name matching 'iTeos Therapeutics Inc.'

Date
Time Source
Company
Announcement
12 May 2022 9:01 pm GNW   iTeos Therapeutics Inc. iTeos Reports First Quarter 2022 Financial Results and Provides Business Update
23 Mar 2022 8:01 pm GNW   iTeos Therapeutics Inc. iTeos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
01 Mar 2022 12:00 pm GNW   iTeos Therapeutics Inc. iTeos to Present at the Cowen 42nd Annual Health Care Conference
10 Feb 2022 12:00 pm GNW   iTeos Therapeutics Inc. iTeos to Participate in Upcoming Investor Conferences in February
10 Jan 2022 12:00 pm GNW   iTeos Therapeutics Inc. iTeos Provides Clinical Development Plans and Promotes Yvonne McGrath, Ph.D. to Chief Scientific Officer
03 Jan 2022 9:01 pm GNW   iTeos Therapeutics Inc. iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference
09 Dec 2021 9:01 pm GNW   iTeos Therapeutics Inc. iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology Annual Meeting and TIGIT Therapies Digital Summit 2021
10 Nov 2021 9:01 pm GNW   iTeos Therapeutics Inc. iTeos Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
03 Nov 2021 11:00 am GNW   iTeos Therapeutics Inc. iTeos to Report Third Quarter 2021 Financial Results on November 10, 2021
01 Sep 2021 12:00 pm GNW   iTeos Therapeutics Inc. iTeos Therapeutics to Participate in Upcoming September Investor Conferences
12 Aug 2021 12:00 pm GNW   iTeos Therapeutics Inc. iTeos Reports Second Quarter 2021 Financial Results and Provides Business Update
05 Aug 2021 12:00 pm GNW   iTeos Therapeutics Inc. iTeos to Report Second Quarter 2021 Financial Results and Provide Corporate Update on August 12, 2021
03 Aug 2021 12:00 pm GNW   iTeos Therapeutics Inc. iTeos Therapeutics to Present at Wedbush PacGrow Healthcare Conference 2021
08 Jul 2021 3:03 pm GNW   iTeos Therapeutics Inc. iTeos Therapeutics to Present at William Blair Biotech Focus Conference 2021
04 Jun 2021 2:00 pm GNW   iTeos Therapeutics Inc. iTeos Therapeutics Announces New Phase 1/2a Data Indicating Antitumor Activity of inupadenant, its Adenosine A2A Receptor Antagonist, at ASCO 2021
26 May 2021 12:00 pm GNW   iTeos Therapeutics Inc. iTeos to Present at the Jefferies Virtual Healthcare Conference
  12:00 pm GNW   iTeos Therapeutics Inc. iTeos to Present at the Jefferies Virtual Healthcare Conference
13 May 2021 9:01 pm GNW   iTeos Therapeutics Inc. iTeos Reports First Quarter 2021 Financial Results and Provides Business Update
06 May 2021 9:01 pm GNW   iTeos Therapeutics Inc. iTeos to Report First Quarter 2021 Financial Results and Provide Corporate Update on May 13, 2021
03 May 2021 9:01 pm GNW   iTeos Therapeutics Inc. iTeos Appoints Tony Ho M.D. and Robert Iannone M.D., M.S.C.E., two Highly Accomplished R&D Executives to its Board of Directors
10 Apr 2021 1:30 pm GNW   iTeos Therapeutics Inc. iTeos Therapeutics Announces New Preliminary Data Indicating Clinical Activity with its Anti-TIGIT Antibody, EOS-448, at the AACR Annual Meeting 2021
24 Mar 2021 8:45 pm GNW   iTeos Therapeutics Inc. iTeos Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
05 Jan 2021 12:00 pm GNW   iTeos Therapeutics Inc. iTeos to Present at the 39th Annual J.P. Morgan Healthcare Conference
12 Nov 2020 12:01 pm GNW   iTeos Therapeutics Inc. iTeos Reports Third Quarter 2020 Financial Results and Provides Business Update
05 Nov 2020 9:05 pm GNW   iTeos Therapeutics Inc. iTeos to Participate in Upcoming Investor Conferences in November
08 Sep 2020 9:05 pm GNW   iTeos Therapeutics Inc. iTeos to Participate in Upcoming Investor Conferences in September
01 Sep 2020 10:26 pm GNW   iTeos Therapeutics Inc. iTeos Reports Second Quarter 2020 Financial Results and Provides Business Update
24 Jul 2020 3:31 am GNW   iTeos Therapeutics Inc. iTeos Therapeutics Announces Pricing of Initial Public Offering


Company Announcements Archive »


a d v e r t i s e m e n t